Cambium Bio Limited (ASX:CMB)
0.5000
+0.0050 (1.01%)
Sep 18, 2026, 1:20 PM AEST
| Market Cap | 14.57M +25.0% |
| Revenue (ttm) | 1.23M +58.2% |
| Net Income | -4.10M |
| EPS | -0.17 |
| Shares Out | 29.43M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,925 |
| Open | 0.4950 |
| Previous Close | 0.4950 |
| Day's Range | 0.4950 - 0.5000 |
| 52-Week Range | 0.3400 - 0.6000 |
| Beta | -0.15 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 4, 2026 |